How Laborate Pharmaceuticals Grew From a Family Enterprise

The transition from a north-centric distribution model to a pan-India network was a turning point for Laborate. This expansion required operational rigor, and the company worked to develop state-level partnerships, enhanced logistics, and trust-building strategies with pharmacies.

By the early 2000s, Laborate had expanded its institutional and export verticals while investing in WHO-GMP-compliant manufacturing facilities, positioning itself for growth in both domestic and international markets.

In 2015, Parag Bhatia, Ajay’s son, joined Laborate after completing his postgraduate studies in International Management. With his international experience, he brought in structure and modernisation to the company. Parag’s leadership helped scale the company’s revenue from ₹300 crore to ₹1,600 crore, expanding into over 55 countries.

Laborate diversified into 3,000+ formulations ranging from generics and nutraceuticals to herbal wellness and personal care, allowing it to strengthen its position as an integrated healthcare solutions provider.

One of Parag's first moves was to build Laborate’s cosmetics and wellness division, tapping into a previously untapped market. As the company diversified, it expanded its portfolio to include nutraceuticals, herbal formulations, and private-label manufacturing for both domestic and international markets.

In addition, Parag led the charge for global certifications, including EU-GMP compliance, which opened doors to markets like the EU, Australia, Canada, and South Africa.

In 2022, Laborate launched Aqualab, a D2R vertical aimed at simplifying last-mile distribution and connecting trusted formulations directly with pharmacists and consumers. This innovation helped deepen the company’s understanding of consumer needs and made its products more accessible.

Parag explains, “Pharmacists were becoming the first point of guidance for everyday wellness. We needed to make it easier for them to access the products their customers asked for.”

This shift represented a key turning point in how Laborate viewed its relationship with the retail ecosystem.

With its continued focus on quality, reliability, and affordability, Laborate Pharmaceuticals is positioned for future growth. The company plans to expand further into global markets and continue innovating in the wellness and diagnostics sectors.

Laborate’s journey from a small family-run business to a global player in the pharmaceutical space highlights the importance of innovation, diversification, and market understanding.